Gene Therapy for Cardiovascular Disorders
Data up to Jan 2025
Total Citations Per Year
Abstract
References (54)
Direct Gene Transfer into Mouse Muscle in Vivo
1990 • 3,985 citations
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
1999 • 2,410 citations
Gene therapy - promises, problems and prospects
1997 • 1,692 citations
Angiogenesis Gene Therapy
1999 • 673 citations
Nonviral Vectors in the New Millennium: Delivery Barriers in Gene Transfer
2001 • 576 citations
Cytostatic Gene Therapy for Vascular Proliferative Disorders with a Constitutively Active form of the Retinoblastoma Gene Product
1995 • 455 citations
[40] Use of retroviral vectors for gene transfer and expression
1993 • 412 citations
Improvement in Survival and Cardiac Metabolism After Gene Transfer of Sarcoplasmic Reticulum Ca 2+ -ATPase in a Rat Model of Heart Failure
2001 • 374 citations
Development of lentiviral vectors for gene therapy for human diseases
2000 • 241 citations
Adeno-associated virus vectors for gene therapy: more pros than cons?
2000 • 229 citations
Production of first generation adenovirus vectors: a review
2000 • 219 citations
In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
1994 • 184 citations
The HIV Tat protein transduction domain improves the biodistribution of β-glucuronidase expressed from recombinant viral vectors
2001 • 159 citations
Prospects for Gene Therapy for Heart Failure
2000 • 155 citations
Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery
1994 • 153 citations
Heat Shock Protein 70 Gene Transfection Protects Mitochondrial and Ventricular Function Against Ischemia-Reperfusion Injury
2001 • 146 citations
Adrenomedullin Gene Delivery Attenuates Hypertension, Cardiac Remodeling, and Renal Injury in Deoxycorticosterone Acetate-Salt Hypertensive Rats
2000 • 122 citations
Gene therapy using HVJ-liposomes: the best of both worlds?
1999 • 106 citations
Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense.
1996 • 105 citations
Thromboresistance of Balloon-Injured Porcine Carotid Arteries After Local Gene Transfer of Human Tissue Factor Pathway Inhibitor
2000 • 95 citations
Local Overexpression of Thrombomodulin for In Vivo Prevention of Arterial Thrombosis in a Rabbit Model
1999 • 92 citations
Gene Correction of the Apolipoprotein (Apo) E2 Phenotype to Wild-type ApoE3 by in Situ Chimeraplasty
2001 • 86 citations
Expression and Function of Recombinant Endothelial Nitric Oxide Synthase Gene in Canine Basilar Artery After Experimental Subarachnoid Hemorrhage
1998 • 81 citations
Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure
2000 • 78 citations
Development of lentiviral vectors for gene therapy for human diseases
2000 • 77 citations
Decoy Administration of NF-κB into the Subarachnoid Space for Cerebral Angiopathy
1998 • 73 citations
Gene therapy to promote thromboresistance: Local overexpression of tissue plasminogen activator to prevent arterial thrombosis in an in vivo rabbit model
1999 • 71 citations
Human Adrenomedullin Gene Delivery Protects against Cardiac Hypertrophy, Fibrosis, and Renal Damage in Hypertensive Dahl Salt-Sensitive Rats
2000 • 71 citations
Gene Transfer of Calcitonin Gene–Related Peptide Prevents Vasoconstriction After Subarachnoid Hemorrhage
2000 • 70 citations
RETRACTED: Prevention of renovascular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy
1998 • 62 citations
Adenoviral Expression of a Urokinase Receptor–Targeted Protease Inhibitor Inhibits Neointima Formation in Murine and Human Blood Vessels
2001 • 62 citations
Improvements in adenoviral vector technology: overcoming barriers for gene therapy
2000 • 56 citations
Losartan Versus Gene Therapy
1997 • 54 citations
Gene delivery and gene therapy with herpes simplex virus-based vectors
2001 • 53 citations
p27-p16 Fusion Gene Inhibits Angioplasty-Induced Neointimal Hyperplasia and Coronary Artery Occlusion
2001 • 46 citations
Sustained Inhibition of Angiotensin I–Converting Enzyme (ACE) Expression and Long-Term Antihypertensive Action by Virally Mediated Delivery of ACE Antisense cDNA
1999 • 42 citations
Gene therapy attenuates the elevated blood pressure and glucose intolerance in an insulin-resistant model of hypertension
2001 • 42 citations
Adenovirus-mediated kallikrein gene delivery attenuates hypertension and protects against renal injury in deoxycorticosterone-salt rats
1999 • 39 citations
Prevention of Restenosis by Gene Therapy
1997 • 38 citations
Expression of exogenous tissue factor pathway inhibitor in vivo suppresses thrombus formation in injured rabbit carotid arteries
2001 • 38 citations
Direct intra-cardiomuscular transfer of β2-adrenergic receptor gene augments cardiac output in cardiomyopathic hamsters
2000 • 32 citations
Adenoviral gene transfer of basic fibroblast growth factor promotes angiogenesis in rat brain
2000 • 32 citations
Recent advances, prospects and problems in designing new strategies for oligonucleotide and gene delivery in therapy.
1998 • 30 citations
Gene Therapy for Treatment of Cerebral Ischemia Using Defective Herpes Simplex Viral Vectors
2001 • 30 citations
In vivo suppression of restenosis in balloon-injured rat carotid artery by adenovirus-mediated gene transfer of the cell surface-directed plasmin inhibitor ATF.BPTI
2001 • 30 citations
Inability to Induce Hypertension in Normotensive Rat Expressing AT 1 Receptor Antisense
2000 • 28 citations
Angiotensin I–Converting Enzyme Antisense Gene Therapy Causes Permanent Antihypertensive Effects in the SHR
2000 • 25 citations
Retroviral vectors
2000 • 21 citations
Human Tissue Kallikrein Attenuates Hypertension and Secretes into Circulation and Urine After Intramuscular Gene Delivery in Hypertensive Rats
1999 • 19 citations
The Potential Role of Antisense Oligodeoxynucleotide Therapy for Cardiovascular Disease
2000 • 15 citations
Prevention of restenosis using the gene for cecropin complexed with DOCSPER liposomes under optimized conditions
2005 • 13 citations
Gene therapy in heart disease
2001 • 9 citations
Antisense oligonucleotides strategy in the treatment of hypertension.
2001 • 8 citations
Gene Therapy for Coronary Artery Disease
2020 • 3 citations